PHR2033
卡巴拉汀相关化合物E
Pharmaceutical Secondary Standard; Certified Reference Material
别名:
(S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium iodide
等级
certified reference material
pharmaceutical secondary standard
质量水平
Agency
traceable to USP 1604950
API类
rivastigmine
CofA
current certificate can be downloaded
包装
pkg of 30 mg
应用
pharmaceutical
包装形式
neat
储存温度
-10 to -25°C
一般描述
Rivastigmine Related Compound E is an impurity of rivastigmine, a novel acetylcholine esterase inhibitor. It is mainly used for the treatment of Alzheimer′s disease.
应用
Rivastigmine may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using electroanalytical technique and high-performance thin layer chromatography method.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.
分析说明
These secondary standards offer multi-traceability to the USP and EP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
To see an example of a Certificate of Analysis for this material enter LRAB4763 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
警示用语：
Danger
危险分类
Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral
储存分类代码
6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Voltammetric determination of rivastigmine in pharmaceutical and biological samples using molecularly imprinted polymer modified carbon paste electrode
Arvand M, et al.
Sensors and Actuators B, Chemical, 188, 797-805 (2013)
Stability-indicating HPTLC determination of rivastigmine in the bulk drug and in pharmaceutical dosage forms
Karthik A, et al.
J. Planar Chromatogr.-Mod. TLC, 20(6), 457-461 (2007)
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持